Physician

Ali Haider, M.D.

According to 2025 Medicare claims, Ali Haider, M.D. (NPI: 1962665265) practices interventional cardiology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Queens, NY. This provider's primary affiliated billing organization is NEW YORK QUEENS MEDICINE AND SURGERY, P.C. (NPI: 1003114851; TIN: 274719998) and primary practice location at 11355-5046. Haider is affiliated with the HARTFORD HEALTHCARE ACCOUNTABLE CARE ORGANIZATION, INC. (ACO ID: A1749), NewYork Quality Care (ACO ID: A2571), and Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Haider's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 204 traditional Medicare patients, billed 824 HCPCS/CPT codes, and received $99,792 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 927 prescription claims across 147 beneficiaries totaling $218,248 in drug costs, led by Entresto (Sacubitril/Valsartan). Open Payments data shows 136 records totaling $44,695. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $336,907 to $99,792. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,602	3,394	$336,907
2016	1,600	4,075	$427,453
2017	1,661	4,420	$475,629
2018	1,539	3,805	$404,721
2019	1,437	3,608	$423,648
2020	1,312	2,896	$328,255
2021	2,066	4,233	$407,752
2022	1,188	2,226	$204,303
2023	156	559	$73,930
2024	204	824	$99,792

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	220	1,264	$51,324
2016	265	1,667	$102,209
2017	336	2,252	$200,921
2018	401	2,770	$347,831
2019	476	3,069	$459,368
2020	484	3,418	$670,738
2021	515	3,623	$831,494
2022	456	3,001	$746,928
2023	263	1,012	$297,479
2024	147	927	$218,248

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	71	73	$144
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	50	92	$105
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	57	85	$103
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	50	52	$13
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	70	79	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	41	2,370	$50,453
Jardiance	Empagliflozin	45	2,340	$44,011
Brilinta	Ticagrelor	40	1,830	$26,159
Xarelto	Rivaroxaban	40	1,320	$24,336
Farxiga	Dapagliflozin Propanediol	24	910	$16,923

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	136	$44,695	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ali Haider, M.D.?

Tedicare shows public-source Medicare data for Ali Haider, M.D. (NPI 1962665265), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Haider, M.D. have ACO affiliation data?

Ali Haider, M.D. is shown with ACO affiliation data for HARTFORD HEALTHCARE ACCOUNTABLE CARE ORGANIZATION, INC. (MSSP, ACO ID A1749), NewYork Quality Care (MSSP, ACO ID A2571), and Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Ali Haider, M.D.?

Ali Haider, M.D. is linked to NEW YORK QUEENS MEDICINE AND SURGERY, P.C. (billing NPI 1003114851) in the available physician profile data.

Does Ali Haider, M.D. have Open Payments data?

Ali Haider, M.D. has 136 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.